March 1, 2019
Kaken Pharmaceutical will develop Arbor Pharmaceuticals’ head lice treatment ivermectin, sold as Sklice Lotion 0.5% in the US, in Japan as strains of the parasite resistant to existing non-prescription drugs are spreading in the country, particularly in Okinawa. The Japanese...read more